Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient

NATerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

May 12, 2025

Study Completion Date

July 7, 2025

Conditions
Benign Prostatic HyperplasiaLower Urinary Tract Symptoms
Interventions
PROCEDURE

Surgical Approach

The surgical laser used will be randomized. All lasers used during this trial are all FDA approved devices and used per routine clinical care.

Trial Locations (1)

66104

University of Kansas Medical Center, Kansas City

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

University of Kansas Medical Center

OTHER

NCT04979143 - Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient | Biotech Hunter | Biotech Hunter